Cetuximab Harmful for Operable CRC Liver Metastases

]]>(MedPage Today) -- Adding cetuximab (Erbitux) to perioperative chemotherapy worsened survival for colorectal cancer (CRC) patients with operable liver metastases, long-term results from a randomized trial showed.With over 5 years of follow-up...